205676-68-2

Basic information

• Product Name: Methyl (+/-)-3-carbomethoxy-4-[2-[N-(tert-butoxycarbonyl)-N-methylamino]methyl-4-methoxyphenyl]butanoate
• Synonyms: Methyl (+/-)-3-carbomethoxy-4-[2-[N-(tert-butoxycarbonyl)-N-methylamino]methyl-4-methoxyphenyl]butanoate
• CAS NO: 205676-68-2
• Molecular Weight: 409.48
• Mol File: 205676-68-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Methyl (+/-)-3-carbomethoxy-4-[2-[N-(tert-butoxycarbonyl)-N-methylamino]methyl-4-methoxyphenyl]butanoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl (+/-)-3-carbomethoxy-4-[2-[N-(tert-butoxycarbonyl)-N-methylamino]methyl-4-methoxyphenyl]butanoate(205676-68-2)
• EPA Substance Registry System: Methyl (+/-)-3-carbomethoxy-4-[2-[N-(tert-butoxycarbonyl)-N-methylamino]methyl-4-methoxyphenyl]butanoate(205676-68-2)

Safety Data

• Hazardous Substances Data: 205676-68-2(Hazardous Substances Data)

Upstream product

• 19614-12-1 2-bromo-5-methoxybenzyl bromide 
• 205676-67-1 3-[N-(tert-butoxycarbonyl)-N-methylamino]methyl-4-bromoanisole 
• 767289-08-7 N-(2-bromo-5-methoxybenzyl),N-methylamine 
• 6163-58-2 tris-(o-tolyl)phosphine 

Downstream Products

• 205676-69-3 methyl (+/-)-3-carbomethoxy-4-[2-(methylamino)methyl-4-methoxyphenyl]butanoate 

Relevant articles and documents

Treatment Method

The present invention is directed to methods of treating an ocular neovascular disorder in a mammal by administration of pyrimidine derivatives, benzodiazepinyl derivatives and pharmaceutical compositions containing the same. The invention encompasses methods of treating an ocular neovascular disorder by administration of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, (S)-3-oxo-8-[3-(pyridin-2-ylamino)-1-propyloxy]-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepine-4-acetic acid or salts or solvates thereof. Combination therapies for the treatment of ocular neovascular disorders are also encompassed.